Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
Clinical trial NCT05029882 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05029882
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2027-11-01
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.